ITCI
Truist Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,736
| Closed | -$757K | – | 2682 |
|
|
2025
Q1 | $757K | Sell |
5,736
-40,420
| -88% | -$5.33M | ﹤0.01% | 1640 |
|
|
2024
Q4 | $3.85M | Buy |
46,156
+268
| +0.6% | +$22.4K | 0.01% | 941 |
|
|
2024
Q3 | $3.36M | Buy |
45,888
+453
| +1% | +$33.1K | 0.01% | 993 |
|
|
2024
Q2 | $3.11M | Sell |
45,435
-18,931
| -29% | -$1.3M | ﹤0.01% | 1065 |
|
|
2024
Q1 | $4.45M | Buy |
64,366
+342
| +0.5% | +$23.7K | 0.01% | 920 |
|
|
2023
Q4 | $4.59M | Buy |
64,024
+2,134
| +3% | +$153K | 0.01% | 891 |
|
|
2023
Q3 | $3.22M | Buy |
61,890
+1,172
| +2% | +$61K | 0.01% | 1014 |
|
|
2023
Q2 | $3.84M | Buy |
60,718
+751
| +1% | +$47.6K | 0.01% | 942 |
|
|
2023
Q1 | $3.25M | Buy |
59,967
+13,555
| +29% | +$734K | 0.01% | 1005 |
|
|
2022
Q4 | $2.46M | Sell |
46,412
-609
| -1% | -$32.2K | ﹤0.01% | 1102 |
|
|
2022
Q3 | $2.19M | Buy |
+47,021
| New | +$2.19M | ﹤0.01% | 1122 |
|